Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

MP CLO VIII Reset Closing

14 Jun 2021 07:00

RNS Number : 7116B
Marble Point Loan Financing Limited
14 June 2021
 

14 June 2021

 

MARBLE POINT LOAN FINANCING LIMITED

CLO RESET CLOSING ANNOUNCEMENT

Marble Point Loan Financing Limited ("MPLF") has closed a CLO Reset transaction for MP CLO VIII Ltd. ("MP CLO VIII"),

CLO Issuer:

MP CLO VIII Ltd.

CLO Collateral Manager:

MP CLO Management LLC

CLO Size:

US$350.0 million

MPLF Existing Investment (30 April 2021 Value):

US$7.25 million

MPLF Incremental Investment

US$0.7 million

MPLF Investment Percentage

43.9% of the CLO equity

Pricing Date:

14 May 2021

Closing Date:

10 June 2021

Reinvestment Period End:

28 April 2026

Jefferies LLC acted as Initial Purchaser.

In connection with the CLO reset, the MP CLO VIII Indenture was fully amended and restated, including all Collateral Quality Tests. The original reinvestment period had ended in October 2019. MP CLO VIII is now expected to have, approximately, a five year reinvestment period, two year non-call period and 13 year maturity. Its expected weighted average cost of debt is LIBOR + 189 basis points(1)

 (1) Figures shown are estimated, unaudited, subject to change and based on the analysis of Marble Point Credit Management LLC, the investment manager of MPLF, as at the Closing Date.

Enquiries:

Marble Point Loan Financing Limited

Investor Relations

T: +44 (0) 20 7259 1500

E: ir@mplflimited.com 

Website: www.mplflimited.com 

Corporate Broker:

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

Financial Public Relations:

Charlie Barker / Catherine Chapman

MHP Communications

T: +44 (0) 20 3128 8100

MarblePoint@mhpc.com

 

 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey-domiciled closed-ended investment company with its ordinary shares ("Shares") admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (ticker: MPLF.LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission.

 

Important Information

This document has been issued by the Company and is the sole responsibility of the Company. This document and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or any of its affiliates. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of any investment and should consult its own legal counsel and financial, actuarial, accounting, regulatory and tax advisers to evaluate any such investment. This document is provided for informational purposes only, does not constitute an offer to sell any Shares or a solicitation of an offer to purchase any Shares in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction, and is not a prospectus. This document may not be relied upon and should not be used for the purpose of making any investment decision.

Past performance is not a reliable indicator of current or future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

This document is for information purposes only. No recipient may forward, reproduce, distribute, or make available in whole or in part, this document (directly or indirectly) to any other person. The distribution of this document in certain jurisdictions may be restricted by law and recipients of this document should inform themselves about and observe any such restrictions and other applicable legal requirements in their jurisdictions. This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Australia, Canada, the Republic of South Africa or Japan or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa or Japan. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States or the laws of other jurisdictions.

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act.

There is no guarantee that any of the goals, targets or objectives described in this document will be achieved. The investment strategies of the Company described herein may not be suitable for all investors and are not intended to constitute a complete investment program. Neither Marble Point nor the Company makes any representation or warranty (express or implied) with respect to the information contained herein (including, without limitation, information obtained from third parties) and each of them expressly disclaims any and all liability based on or relating to the information contained in, or errors or omissions from, these materials; or based on or relating to the use of these materials; or any other written or oral communications transmitted to the recipient or any of its affiliates or representatives in the course of its evaluation of the information herein.

None of the Company, Marble Point or any of their respective parent or subsidiary undertakings, or the subsidiary undertaking of any such parent undertakings, or any of such person's respective partners, shareholders, directors, members, officers, affiliates, agents, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any information or opinions presented or contained in this document nor shall they accept any responsibility whatsoever for, or make any warranty, express or implied, as to the truth, fullness, accuracy or completeness of the information in this document (or whether any information has been omitted from the document) or any other information relating to the Company, Marble Point or their respective subsidiaries or associated companies, in any form whatsoever, howsoever transmitted or made available or for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection therewith. This shall not affect any liability any such person may have which may not be excluded under applicable law or regulation.

A Note on Forward Looking Statements. This document includes forward-looking statements. Forward-looking statements include all matters that are not historical facts. Actual results may differ materially from any results projected in the forward-looking statements and are subject to risks and uncertainties. Such statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, and other factors that may cause actual results to differ materially from the anticipated results expressed or implied by such forward-looking statements. The Company and Marble Point caution readers not to place undue reliance on such statements. Neither the Company nor Marble Point undertakes, and each specifically disclaims, any obligation or responsibility, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company's and/or Marble Point's expectations and estimates.

The information provided herein is estimated, unaudited, for background purposes only, representative as at the dates specified herein, subject to adjustment and not purported to be full or complete. Nothing herein shall be relied upon as a representation as to the current or future performance or portfolio holdings of the Company or any strategy or investment vehicle. Certain information presented herein has been obtained from third party sources and is believed to be reliable. However, neither the Company nor Marble Point represents that the information contained in this document (including third party information) has been independently verified or is accurate or complete, and it should not be relied upon as such. Index information, if any, has been provided for illustration purposes only. Any such information does not reflect the effect of transaction costs, management fees or other costs which would reduce returns. An investor cannot invest directly in an index.

Any of the views or opinions expressed herein are current views and opinions only and may be subject to change. Statements made herein are as of the date of this document and should not be relied upon as of any subsequent date. All information is current as of the date of this document and is subject to change without notice.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFFLIRDILLIL
Date   Source Headline
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th Jan 20236:00 pmRNSDividend Declaration
12th Jan 20236:17 pmRNSMPLF Director / PDMR Shareholding
12th Jan 20236:00 pmRNSCompany Investment Manager Acquired by Investcorp
10th Jan 20236:00 pmRNSHolding(s) in Company
28th Dec 20226:00 pmRNSDividend Declaration
22nd Dec 20226:30 pmRNSNotice of Ordinary Share Re-designation
22nd Dec 20226:30 pmRNSChanges to the Board of Directors
21st Dec 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
2nd Dec 20227:30 amRNSCompany Investment Manager Agrees to Combination
22nd Nov 20226:00 pmRNS3rd Quarter Results
22nd Nov 20227:00 amRNSNet Asset Value & Publication of Monthly Report
17th Nov 20227:00 amRNSResults of General Meeting
17th Nov 20227:00 amRNSResults of Annual General Meeting
26th Oct 20227:00 amRNSNotice of Annual General Meeting
25th Oct 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Oct 20226:00 pmRNSSterling Dividend Amount
29th Sep 20227:00 amRNSDividend Declaration
21st Sep 20227:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20226:00 pmRNSHalf-Year Report
19th Aug 20227:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jul 20227:00 amRNSIssue of Equity
22nd Jul 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Jul 20226:00 pmRNSDividend Declaration
15th Jul 20227:00 amRNSPublication of Key Investor Document
30th Jun 20227:00 amRNSDividend Declaration
23rd Jun 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Jun 20227:00 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th Jun 20225:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.